Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Glioblastoma × Evoked Potentials × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioblastoma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 9 Magnetic Resonance Spectroscopy 7 Radiotherapy 5 Surveys and Questionnaires 4 Transurethral Resection of Bladder 3 Surgical Procedures, Operative 3 Blood Specimen Collection 3 Radiation 2 Perfusion Magnetic Resonance Imaging 2 Magnetic Resonance Imaging 2 Chemoradiotherapy 2 Amplified Fragment Length Polymorphism Analysis 2 regorafenib 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 gadodiamide 1 apatinib 1 Ultrasonography 1 Trail Making Test 1 Tablets 1 Standard of Care 1 Specimen Handling 1 Sampling Studies 1 Psychometrics 1 Proton Magnetic Resonance Spectroscopy 1 Photochemotherapy 1 Pharmacogenomic Testing 1 Palliative Care 1 Oxygen-15 1 Observation 1 Niacinamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06273176 2024-02-22

RECMAP

Erasmus Medical Center

Astrocytoma, Brain Neoplasms, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡